DocMorris AG announces number of shares sold in rights offering – Biotech Investments

by Biotech Newsroom


Release of an ad hoc announcement pursuant to Art. 53 LR

The issuer is solely responsible for the content of this announcement.

Frauenfeld, 21 May 2025

Press release

Ad hoc announcement pursuant to Art. 53 LR

DocMorris AG announces number of shares sold in rights offering

DocMorris AG (“DocMorris”) announces that c.98.7% of the subscription rights under the rights offering started on May 8, 2025, have been validly exercised by the end of the subscription period on May 21, 2025, at 12:00 noon CEST.

It is planned that the remaining 483,900…



Source link

You may also like

Houston, TX – (EmailWire) — The Biotech Times™ aggregates, publishes and distributes news about the Biotech Industry. In association with EmailWire™, The Biotech Times, helps businesses and organizations in the industry with press release distribution. Press releases are disseminated to journalists, experts, investors, trade publications and other related media outlets. For more information, contact us through the following messaging apps:

Free Magazines

Recent Articles

BioTech Times™ is part of GroupWeb Media Network. © 2026 GroupWeb Media LLC